Retigabine Immediate Release
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Retigabine Immediate Release, covering 2014-09-08 to 2014-09-08. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures [Phase 3]